Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|July 11, 2026
Targeting Lung Cancer Metabolism: Therapeutic Opportunities and ChallengesCatarina Freitas-Dias, Cindy Mendes
Advances in Experimental Medicine and Biology|July 11, 2026
Use of Nuclear Magnetic Resonance (NMR) to Study Cancer MetabolismCatarina Freitas-Dias, Luís Gafeira Gonçalves
Advances in Experimental Medicine and Biology|July 11, 2026
Cell-Free DNA (cfDNA), Its Applications in Cancer Diagnosis and Monitoring, and Its Potential Role in Regulating Cancer MetabolismCatarina Freitas-Dias, Isabel Lemos, Stefano Mazzoleni, et al.
Cells|February 23, 2024
Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTECatarina Freitas-Dias, Filipe Gonçalves, Filipa Martins, et al.
Metabolites|April 25, 2025
Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific MannerIsabel Lemos, Catarina Freitas-Dias, Ana Hipólito, et al.
Metabolites|April 25, 2025
Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell LineIsabel Lemos, Catarina Freitas-Dias, Ana Hipólito, et al.
FEBS Open Bio|March 16, 2026
Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activityAdriana Cruz, Bruna Abreu, Cindy Mendes, et al.
Bioscience Reports|July 11, 2024
Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cellsCindy Mendes, Isabel Lemos, Ana Hipólito, et al.
Discover Oncology|April 17, 2026
Polycationic dendrimers synergizes with gefitinib to overcome EGFREx19Del-driven resistance in non-small-cell lung cancerAdriana Cruz, Bruna Abreu, Cindy Mendes, et al.
Pageof 1